Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

@article{Silk2004UtilizingTA,
  title={Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.},
  author={Jonathan D. Silk and Ian F Hermans and Uzi Gileadi and Tsung Wen Chong and Dawn Shepherd and Mariolina Salio and Bini Mathew and Richard R Schmidt and Sarah Jane Lunt and Kaye J. Williams and Ian James Stratford and Adrian L. Harris and Vincenzo Cerundolo},
  journal={The Journal of clinical investigation},
  year={2004},
  volume={114 12},
  pages={1800-11}
}
Activation of invariant CD1d-dependent NK T cells (iNKT cells) in vivo through administration of the glycolipid ligand alpha-galactosylceramide (alpha-GalCer) or the sphingosine-truncated alpha-GalCer analog OCH leads to CD40 signaling as well as the release of soluble molecules including type 1 and gamma interferons that contribute to DC maturation. This process enhances T cell immunity to antigens presented by the DC. The adjuvant activity is further amplified if APCs are stimulated through… CONTINUE READING
75 Citations
60 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 75 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

  • M Nieda
  • Blood .
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…